Plus: type 2 & flash glucose monitors; stroke and hyperglycemia
Jan. 14, 2020: DCMS #484 TOP STORIES - Diabetes News & Research |
|
Letter from the Editor
Jan. 14, 2020
I was speaking with our intern Usif Darwish, PharmD Candidate, Florida A&M University, about the causes of type 1 diabetes, and he focused on autoimmune problems destroying the beta cells.
He wondered out loud if using an autoimmune blocking drug would prevent diabetes in relatives of patients already diagnosed.
As you probably guessed, his thought became his assignment, and this week he brings us a feature on the value of using a monoclonal antibody drug.
We have moved our newsletters to a new server in order to provide you with a more robust experience. Please make sure to add news@mail.diabetesincontrol.com to your contacts/whitelist so you don’t miss a single issue.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief |
|
| Doctor's Option lab test products include rapid tests and CLIA certified fingerstick lab tests.
Rapid tests offer immediate test results to provide doctors with point of care test results in as little as 90 seconds.
Fingerstick lab tests provide CLIA certified lab accurate results. Each fingerstick lab test collection kit comes with a prepaid postage return envelope and everything you need to obtain and collect your fingerstick blood sample in a 510K FDA approved device.
Fingerstick lab tests are great for people who want to monitor their blood sugar, cholesterol, lipids and other important bio-markers at home or on the go.
Visit Doctor's Option |
|
|
|
|
TOP STORIES - Diabetes News and Research |
|
| Teplizumab as Prophylaxis Therapy
The study findings shed light on the viability of a potential prophylactic treatment of type 1 diabetes in direct relatives of current patients |
| |
|
|
|
|
| | | | About LaterPay: You will notice that some of our articles are now marked with a small credit card icon. This means you will be asked to pay a small fee to access the full article text (the cost is $0.39 per article, and you will be charged only after you have reached $5.00 in article views). The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control. |
| Your Friends in Diabetes Care
Steve and Dave
Diabetes In Control
810 Bear Tavern Road Suite 102
Ewing, NJ, 08628
USA
www.diabetesincontrol.com |
|
|
|
|
| | |
|
|
|
|
